National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 7/6/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

4/5/2013

Ellin Berman, MD

None

None

None

None

1/22/2013

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

7/2/2012

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Enzon Pharmaceuticals;
Novartis Pharmaceuticals Corporation

None

None

9/5/2013

Marcel P. Devetten, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

12/30/2009

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation;
Takeda Pharmaceuticals North America, Inc.

None

None

5/14/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

3/21/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Madan Jagasia, MD

None

None

None

None

4/1/2012

Joan S. McClure, MS

None

None

None

None

8/13/2013

Joseph O. Moore, MD

None

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/15/2014

Susan O'Brien, MD

None

None

None

None

8/27/2013

Javier Pinilla-Ibarz, MD, PhD

None

Novartis Pharmaceuticals Corporation;
Innovive

None

None

9/3/2013

Jerald P. Radich, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

1/29/2013

Neil P. Shah, MD, PhD

None

None

None

None

10/22/2013

Paul J. Shami, MD

None

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

1/28/2013

B. Douglas Smith, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

1/19/2013

David S. Snyder, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

4/1/2014

Hema Sundar, PhD

None

None

None

None

1/13/2014

Moshe Talpaz, MD

None

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/6/2009

Meir Wetzler, MD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

8/16/2013

Furhan Yunus, MD, FACP

None

None

None

None

4/2/2012